NDC 31722-736 – Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate

Efavirenz 600 mg/1; Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC31722-736

Product details

Brand name
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203053
Marketed since
January 24, 2022
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Efavirenz, emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
31722-736-3030 TABLET, FILM COATED in 1 BOTTLE (31722-736-30)Jan 24, 2022

Other Efavirenz, emtricitabine and tenofovir disoproxil fumarate products